Survival of patients with type 1 diabetes receiving renal replacement therapy in 1980-2007

Diabetes Care

Volumn 33, Issue 8, 2010, Pages 1718-1723

  Haapio, Mikko ^a   Helve, Jaakko ^a   Groop, Per Henrik ^a   Grönhagen Riska, Carola ^a   Finne, Patrik ^b,c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b Finnish Registry for Kidney Diseases   (Finland)

^c UNIVERSITY OF TAMPERE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; RENAL REPLACEMENT THERAPY; SURVIVAL RATE;

ADULT; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

EID: 77958157960     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-0030     Document Type: Article

References (14)

1. U.S. Renal Data System. USRDS 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2007
2. Lammi N, Blomstedt PA, Moltchanova E, Eriksson JG, Tuomilehto J, Karvonen M. Marked temporal increase in the incidence of type 1 and type 2 diabetes among young adults in Finland. Diabetologia 2008;51:897-899
3. Harjutsalo V, Sjöberg L, Tuomilehto J. Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet 2008;371:1777-1782
4. Finnish Registry for Kidney Diseases. Report 2007 [article online], 2008. Available from http://www.musili.fi/smtr/english. Accessed 16 June 2010
5. Finne P, Reunanen A, Stenman S, Groop PH, Grönhagen-Riska C. Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA 2005;294:1782-1787
6. ESRD Incidence Study Group, Stewart JH, McCredie MR, Williams SM. Divergent trends in the incidence of end-stage renal disease due to type 1 and type 2 diabetes in Europe, Canada and Australia during 1998-2002. Diabet Med 2006;23: 1364-1369
7. Van Dijk PC, Jager KJ, Stengel B, Grönhagen-Riska C, Feest TG, Briggs JD. Renal replacement therapy for diabetic endstage renal disease: data from 10 registries in Europe (1991-2000). Kidney Int 2005; 67:1489-1499
8. Sørensen VR, Mathiesen ER, Heaf J, Feldt- Rasmussen B. Improved survival rate in patients with diabetes and end-stage renal disease in Denmark. Diabetologia 2007; 50:922-929 (Pubitemid 46559250)
9. Villar E, Chang SH, McDonald SP. Incidences, treatments, outcomes, and sex effect on survival in patients with end-stage renal disease by diabetes status in Australia and New Zealand (1991-2005). Diabetes Care 2007;30:3070-3076
10. Rabindranath KS, Adams J, Ali TZ, Daly C, Vale L, Macleod AM. Automated vs continuous ambulatory peritoneal dialysis: a systematic review of randomized controlled trials. Nephrol Dial Transplant 2007;22:2991-2998 (Pubitemid 350093475)
11. Nessim SJ, Bargman JM, Austin PC, Nisenbaum R, Jassal SV. Predictors of peritonitis in patients on peritoneal dialysis: results of a large, prospective Canadian database. Clin J Am Soc Nephrol 2009;4:1195-1200
12. National Kidney Foundation. K/DOQI clinical practice guidelines and clinical practice recommendations for 2006 updates: hemodialysis adequacy, peritoneal dialysis adequacy and vascular access. Am J Kidney Dis 2006;48(Suppl. 1):S1-S322
13. Soedamah-Muthu SS, Chaturvedi N, Witte DR, Stevens LK, Porta M, Fuller JH, EURODIAB Prospective Complications Study Group. Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS). Diabetes Care 2008;31:1360-1366
14. Sarnak MJ. Cardiovascular complications in chronic kidney disease. Am J Kidney Dis 2003;41:11-17